Sino Biopharmaceutical buys back €81.5 million 0% convertibles

By Mary-Katherine Stinson

Lexington, Ky., May 4 – Sino Biopharmaceutical Ltd. repurchased €81.5 million of its 0% convertible bonds due 2025 as of May 4, according to a company notice.

The purchase represents 10.9% of the €750 million originally issued.

The repurchased bonds will be canceled as soon as practicable.

Following the cancellation, there will be €668.5 million outstanding.

Sino Biopharmaceutical is a Hong Kong-based medicine products business.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.